Fıratlı Tuğlular, Ayşe TülinPehlivan, MustafaSönmez, MehmetKabukçu Hacıoğlu, SibelSaydam, GürayAyyıldız, OrhanKaynar, LeylagülDemirkan, FatihBeksaç, Meral2023-03-102023-03-102022Fıratlı Tuğlular, A. T., Pehlivan, M., Sönmez, M., Kabukçu Hacıoğlu, S., Saydam, G., Ayyıldız, O. ... Beksaç, M. (2022). Post-authorization safety of lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma in Turkey. Clinical Lymphoma, Myeloma & Leukemia içinde (S190-S191. ss.).2152-26502152-2669https://hdl.handle.net/20.500.12511/10608[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessRelapsed/Refractory MultipleDexamethasoneLenalidomideConference Object22S190S191Q300895909200334